enVVeno Medical Corporation (NVNO): Market Cap to Revenue

Symbol and logo of brand enVVeno Medical Corporation (NVNO)

Supplying clinics with sterile implants requires flawless logistics to save lives. The development of the vein bioprostheses ecosystem depends entirely on FDA approval. The P/S multiple demonstrates the balance between market price and operating revenue, where reflects the latest value of the metric. The price action of enVVeno Medical (NVNO) is constrained by strict regulators and unique patents for VBR valves.

NVNO enVVeno Medical Corporation P/S Multiple (07/04/2022 - 11/16/2026)

Analytical breakdowns for envveno.com (NVNO)

- stock exchange capitalization data:
General company analysis:NVNO enVVeno Medical Corporation
Core merchandise of enVVeno Medical

The P/S ratio determines the market value of one dollar of revenue, allowing for an assessment of investment expectations regarding revenue growth rates. This metric compares total market capitalization to sales volume, revealing whether the market is overpaying for future success or underestimating the business. By analyzing the P/S ratio chart for enVVeno Medical (NVNO), one can observe the impact of venous valve clinical validation stages on market confidence. However, the lack of operating leverage and rising center costs are constraining the expansion of the multiple.

Competitors of enVVeno Medical

Market Cap to Revenue Boston Scientific Corporation BSX|P/S Multiple EW (Edwards Lifesciences)|ResMed Corp (RMD) - Price to Sales|Insulet Corp - P/S Multiple|ZBH (zimmerbiomet.com) - Market Cap to Revenue Ratio|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (NuVasive) - P/S Multiple|TransMedics Corp (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Artivion, Inc. AORT|P/S Multiple ENOV (enovis.com)|P/S Multiple Integra LifeSciences Corp IART|ESTA - Price-to-Revenue Ratio|BBNX: Price-to-Revenue Ratio|IRMD (IRADIMED CORPORATION) - Market Cap to Revenue|Embecta Corp. - Market Capitalization-to-Revenue Ratio|TNDM (Tandem Corp) - P/S Multiple|Price to Sales AxoGen Inc AXGN|Price-to-Revenue Ratio SI-BONE Inc (SIBN)|Orthofix Medical Inc. (OFIX) - Price-to-Revenue Multiple|P/S Multiple BVS (bioventus.com)|P/S Multiple OrthoPediatrics Inc. KIDS|Treace Medical Concepts Inc - P/S Multiple|Price-to-Revenue Coefficient Blade Air Mobility SRTA|Carlsmed (CARL) - Price-to-Revenue Ratio|Price-to-Sales Ratio RXST (RxSight Ophthalmic)|Price-to-Revenue Ratio clearpointneuro.com|Market Cap to Revenue Stereotaxis, Inc. (STXS)|P/S Multiple STIM|SGHT - Price to Sales|Price-to-Revenue Ratio Orchestra BioMed, Inc. OBIO|ANIK: Market Cap to Revenue Ratio|NSPR: Market Cap to Revenue|Jin Medical - Market Cap to Sales Volume|VANI (Vivani Medical Inc) - Market Cap to Revenue|Market Cap to Revenue Ratio XTNT|NMTC (n1mtc.com) - P/S Multiple|Price to Sales Modular Medical MODD|Price-to-Revenue Ratio myomo.com (MYO)|Price-to-Revenue Ratio COCH (envoymedical.com)|Price-to-Revenue Ratio Vivos Therapeutics Inc VVOS|Market Cap to Sales Volume SINT (sintx.com)|TNON - Price-to-Revenue Ratio|LFWD: Price-to-Revenue Ratio|autonomix.com (AMIX) - Price-to-Revenue Ratio|Price to Sales invobioscience.com (IVF)|BBLG (Bone Biologics Corp.) - P/S Multiple|Axonics Modulation Technologies (AXNX) - Price-to-Revenue Coefficient|Market Cap to Revenue BIOL (Biolase, Inc.)|Dynatronics - Market Cap to Revenue Ratio|Paragon 28, Inc. - Market Cap to Revenue|Price-to-Revenue Coefficient INVO Bio (INVO)